您好,欢迎来到阿仪网! 请登录 免费注册

  • 高级会员服务
  • |
  • 广告位服务
  • |
  • 设为首页
  • |
  • 收藏本站
  • |
  • 诚信档案

    • 会员类型:旗舰版会员
    • 阿仪网旗舰版会员:9年
    • 工商认证【已认证】
    • 最后认证时间:
    • 注册号: 【已认证】
    • 法人代表: 【已认证】
    • 企业类型:经销商 【已认证】
    • 注册资金:人民币50万 【已认证】
    • 产品数:

上海雅吉生物科技有限公司 主营产品:ELISA试剂盒,免疫组化试剂盒,PCR检测盒,金标试纸,发光试剂盒,抗体,血清,细胞等

第9年

当前位置:阿仪网>上海雅吉生物科技有限公司>技术文章>文献引用产品|人胰腺癌细胞AsPC-1

企业档案

会员类型:旗舰版

已获得阿仪网信誉   等级评定
90成长值

(0 -40)基础信誉积累,可浏览访问

(41-90)良好信誉积累,可接洽商谈

(91+  )优质信誉积累,可持续信赖

阿仪网旗舰版会员:9年

工商认证 【已认证】

最后认证时间:

注册号: 【已认证】

法人代表: 【已认证】

参观次数:7948944

手机网站:http://wap.app17.com/c137908/

旗舰版网址:http://www.yajiml.com

技术文章

文献引用产品|人胰腺癌细胞AsPC-1

点击次数:606 发布时间:2026/7/3 9:58:21

文章标题:Effects of NK cell-related lncRNA on the immune microenvironment and molecular subtyping for pancreatic ductal adenocarcinoma

影响因子:5.9

期刊:Frontiers in Immunology

作者列表:Jinze Li, Chuqi Xia, Yuxuan Li, Hanhan Liu, Cheng Gong, Daoming Liang

发表时间:2025-3-28

DOI:10.3389/fimmu.2024.1514259

主要研究成果:Background: Patients with pancreatic ductal adenocarcinoma (PDAC) face a highly unfavorable outcome and have a poor response to standard treatments. Immunotherapy, especially therapy based on natural killer (NK) cells, presents a promising avenue for the treatment of PDAC.

Aims: This research endeavor seeks to formulate a predictive tool specifically designed for PDAC based on NK cell-related long non-coding RNA (lncRNA), revealing new molecular subtypes of PDAC to promote personalized and precision treatment.

Methods: Utilizing the Tumor Immune Single-cell Hub 2 platform, we discovered genes associated with NK cells in PDAC. We employed the TCGA-PAAD dataset to ascertain the expression profiles of these NK cell-related genes and to screen for lncRNAs correlated with NK cells. Subsequently, we utilized Cox regression analysis for hazard ratios and LASSO regression analysis to identify three NK cell-related lncRNAs that were used to develop a prognostic assessment model. The forecasting accuracy of this model was appraised using the ROC curve and validated using a test set and the complete dataset.

Results: Successful construction of a prognostic model comprising three lncRNAs was achieved, demonstrating good predictive efficiency in the training set, validation dataset, and the entire dataset. NK cells display robust interactions with malignant cells, CD8 T cells, and fibroblasts in the PDAC tumor microenvironment and participate in the transport of various signaling molecules and following immune responses in PDAC. According to the expression patterns of NK cell-related lncRNA, we labeled PDAC patients as four molecular subtypes, exhibiting significant differences in immune cell infiltration, drug sensitivity, and other aspects.

Conclusion: This study Uncovered the activity of NK cells within PDAC, proposed an NK cell-related lncRNA model, and delineated new molecular subtypes, thereby providing targets for personalized therapy.


原创作者:上海雅吉生物科技有限公司

推荐产品

在线咨询5分钟应答

提交